Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment.
about
Dendrimer ProdrugsCo-delivery of carboplatin and paclitaxel via cross-linked multilamellar liposomes for ovarian cancer treatment.A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors.Chemo/Photoacoustic Dual Therapy with mRNA-Triggered DOX Release and Photoinduced Shockwave Based on a DNA-Gold Nanoplatform.Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy.Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing Therapies.Recent advances of cocktail chemotherapy by combination drug delivery systems.Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment.Curcumin Nanotechnologies and Its Anticancer Activity.Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer.Multifunctional platinum-based nanoparticles for biomedical applications.EGCG/gelatin-doxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer treatment.Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy.Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives.Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior.Synergistic chemotherapeutic effect of sorafenib-loaded pullulan-Dox conjugate nanoparticles against murine breast carcinoma.Multifunctional nanoparticle composites: progress in the use of soft and hard nanoparticles for drug delivery and imaging.Tunable Lipidoid-Telodendrimer Hybrid Nanoparticles for Intracellular Protein Delivery in Brain Tumor Treatment.Sensitization of lung cancer cells by altered dimerization of HSP27.Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook.Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy.Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment.Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer.Combinatorial approaches in post-polymerization modification for rational development of therapeutic delivery systems.Multifunctional Telodendrimer Nanocarriers Restore Synergy of Bortezomib and Doxorubicin in Ovarian Cancer Treatment.Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity
P2860
Q26743392-D80A6D33-0E9B-4E02-8A70-4F84D70788B8Q33742311-16E6F769-5FE9-4482-A27A-86AF17FE73F5Q35232504-227B25B5-6D55-40D9-B511-3522CBA843ABQ35872986-9D48E684-8D6F-4371-AD68-5DE34C717668Q36326103-8F528446-C41D-4FEB-A814-58C1BA549C25Q36787517-EAC997DF-2F31-4916-9D2D-B32935C2EF87Q37206908-5DDCED40-8181-4BD1-9883-9396615439F6Q37702449-418D4D14-9F73-419A-ADDB-878BAEFC48C5Q38746695-F65AA6EC-29E6-401D-B288-2881C6071666Q38809683-60FCEE61-6551-46C3-9567-2C1D5ED2D50DQ38812240-89C12D90-CC32-4746-82C5-07D0AC94E94EQ38812845-0B8EC7C1-2F40-455A-B8B2-282E5D209347Q38836010-540021D6-D9E4-4F4F-82FC-1891861B2684Q38854876-59F60FDA-46D1-40F6-9A1F-11909831BED2Q38856246-45854B3F-6CD1-49C0-9C5E-BDBED87F9871Q38982260-713D56F4-323E-45CA-A787-E96936B066E0Q39181552-5AF79BBF-88A1-42DC-961D-8AFAB0D7A14EQ41849358-4B97CF59-3026-4D11-AC71-06743B2AAD26Q47153331-A32ECF0A-DFE1-4A7B-9C19-4180F802B342Q47760026-B53F2971-35D6-4F25-9256-DD33B63E046FQ47808831-5AFC9D11-6E19-4D05-AF8B-37B7E23D256FQ49714833-F4045B1A-2B29-41EC-89B6-0A1F03C1F41BQ49797582-FFDE4C88-AC23-44DC-A3E1-0C628BD02498Q52588639-9B7B41EF-A93F-4BE2-9014-1B09FA3B322AQ55265735-BAE6591E-23F3-4993-BAC4-1D5550DC131FQ57483617-023C36EA-B4DA-4139-BD8B-6BBCEC399C50
P2860
Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Telodendrimer nanocarrier for ...... for ovarian cancer treatment.
@ast
Telodendrimer nanocarrier for ...... for ovarian cancer treatment.
@en
type
label
Telodendrimer nanocarrier for ...... for ovarian cancer treatment.
@ast
Telodendrimer nanocarrier for ...... for ovarian cancer treatment.
@en
prefLabel
Telodendrimer nanocarrier for ...... for ovarian cancer treatment.
@ast
Telodendrimer nanocarrier for ...... for ovarian cancer treatment.
@en
P2093
P2860
P1433
P1476
Telodendrimer nanocarrier for ...... for ovarian cancer treatment.
@en
P2093
Changying Shi
Dandan Guo
Juntao Luo
Liqiong Cai
P2860
P304
P356
10.1016/J.BIOMATERIALS.2014.10.044
P50
P577
2014-10-31T00:00:00Z